Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:2451-2457
doi: 10.1161/CIRCULATIONAHA.106.683235
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bunch, T. J.
Right arrow Articles by Gersh, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bunch, T. J.
Right arrow Articles by Gersh, B. J.
Related Collections
Right arrow Ablation/ICD/surgery
Right arrow Acute myocardial infarction
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2007;115:2451-2457.)
© 2007 American Heart Association, Inc.


Contemporary Reviews in Cardiovascular Medicine

Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors

Insights From the Randomized Trials of Implantable Cardioverter-Defibrillators

T. Jared Bunch, MD; Stefan H. Hohnloser, MD; Bernard J. Gersh, MB, ChB, DPhil, FRCP

From the Division of Cardiovascular Disease, Department of Internal Medicine, Mayo Clinic, Rochester, Minn (T.J.B., B.J.G.), and J.W. Goethe University, Frankfurt, Germany (S.H.H.).

Correspondence to Bernard J. Gersh, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail Gersh.bernard@mayo.edu


Key Words: arrhythmia • death, sudden • defibrillation • ischemia • myocardial infarction • revascularization • tachyarrhythmias


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Sudden death is a catastrophic but unpredictable complication of coronary artery disease and is frequently the consequence of an acute ischemic event.1–3 The efficacy of the implantable cardioverter-defibrillator (ICD) in reducing sudden cardiac death incidence is irrefutable and strongly supported by evidence from randomized trials of both primary and secondary prevention (Figure 1).4–8 Nonetheless, the 2 neutral trials9,10 raise intriguing and puzzling issues in regard to the temporal relationship between myocardial infarction (MI), coronary revascularization, residual myocardial ischemia, and severe left ventricular dysfunction and its impact on the mechanisms of presumed sudden cardiac death and the efficacy of the ICD. In this respect, this commentary addresses current knowledge regarding the mechanisms of death early and late after MI, limitations in our abilities to stratify risk, and analyses from the randomized trials in an attempt to reconcile the apparently paradoxical observation that the highest rate of sudden cardiac death occurs the first few weeks after MI and that the only ICD trial to address this population was neutral.10


Figure Removed (Available Only in the Full Text)
View larger version (28K):



 
Figure 1. The efficacy of ICD for the primary prevention of death. Data were derived from the study by Solomon et al26 and from the randomized ICD trials for both primary and secondary prevention of sudden cardiac death.4–8


*    Mechanisms of Death After MI
 
The causes of death after MI are multifactorial and depend in part on the duration of time that has elapsed since the initial MI. During the acute phase of the MI, sudden death is typically the result of ischemia that provokes lethal ventricular . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. E. Belevych, D. Terentyev, S. Viatchenko-Karpinski, R. Terentyeva, A. Sridhar, Y. Nishijima, L. D. Wilson, A. J. Cardounel, K. R. Laurita, C. A. Carnes, et al.
Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death
Cardiovasc Res, December 1, 2009; 84(3): 387 - 395.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. S. Adabag, T. M. Therneau, B. J. Gersh, S. A. Weston, and V. L. Roger
Sudden Death After Myocardial Infarction
JAMA, November 5, 2008; 300(17): 2022 - 2029.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
J. J. Bax, O. Kraft, A. E. Buxton, J. G. Fjeld, P. Parizek, D. Agostini, J. Knuuti, A. Flotats, J. Arrighi, A. Muxi, et al.
123I-mIBG Scintigraphy to Predict Inducibility of Ventricular Arrhythmias on Cardiac Electrophysiology Testing: A Prospective Multicenter Pilot Study
Circ Cardiovasc Imaging, September 1, 2008; 1(2): 131 - 140.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. L. del Rio, P. I. McConnell, M. Kukielka, R. Dzwonczyk, B. D. Clymer, M. B. Howie, and G. E. Billman
Electrotonic remodeling following myocardial infarction in dogs susceptible and resistant to sudden cardiac death
J Appl Physiol, February 1, 2008; 104(2): 386 - 393.
[Abstract] [Full Text] [PDF]